Skip to content

Effect of woodsmoke on the respiratory health of adults with and without chronic respiratory diseases

Effect of woodsmoke on the respiratory health of adults with and without chronic respiratory diseases - Panel study woodsmoke and health

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON49800
Enrollment
100
Registered
2020-11-05
Start date
2021-02-02
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress ten gevolge van houtrook acute stress asthma COPD

Interventions

None listed

Sponsors

Universiteit Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Participant is 30 years or older Participant lives in the participating study area Participants for the asthma/COPD panel need to comply with the following criteria: o Self-reported doctors diagnosis of asthma/COPD. o Report of wheezing, shortness of breath And/or use of asthma/COPD medication in the past 12 months. Participants for the healthy adult panel need to comply with the following criteria: o No self-report of a doctor diagnosis of asthma/COPD ever o No report of wheezing, shortness of breath, chronic cough, phlegm in the past 12 months o No use of asthma/COPD medication in the past 12 months

Exclusion criteria

Exclusion criteria: Active smokers Subjects with a wood stove or fireplace People with absolute contra-indications for spirometry: o Heart attack in the last three months o Chest or abdominal surgery in the past 3 months o A brain, ear or eye surgery in the past 1 month

Design outcomes

Primary

MeasureTime frame
The main study endpoints are lung function (FEV1 and PEF), daily respiratory symptoms, use of bronchodilator medication, and cortisol.

Secondary

MeasureTime frame
Secondary parameters include inflammatory markers Interleukin (IL) 1b, IL-6, IL-8, IL-10, and tumour necrosis factor (TNF)*.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)